NCT04659668View on ClinicalTrials.gov

Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina.

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 11, 2019

Primary Completion Date

June 12, 2020

Study Completion Date

August 17, 2020

Conditions
Vaginal AtrophyVulvovaginal Signs and SymptomsDyspareuniaUrinary Incontinence
Interventions
DEVICE

MMG-23-04-2019

"The dermal filler MMG-23-04-2019 is applied to the female intimate area (intramucosal administration) of vaginal vestibule, vaginal walls, clitoris, G spot."

Trial Locations (1)

1592

Medical Centre Ramus, Sofia

All Listed Sponsors
lead

Mesoestetic Pharma Group S.L.

INDUSTRY

NCT04659668 - Evaluation of the Efficacy and Safety of the Dermal Filler for Female Intimate Area Hydration and Atrophy of the Vagina. | Biotech Hunter | Biotech Hunter